09.12.23 -- Akamis Bio Takes On Advanced Solid Tumors

By standardizing the cell therapy process and common tools across both allogeneic and autologous applications, operators can enable greater speed and reduce the potential for error during the process.

Ensuring transformative medicines make it to patients in need requires risk mitigation strategies that improve the quality of raw materials while facilitating scale-up processes to meet global demand.

While barrier films in bags can be useful for cold chain applications, they do not fully protect against gas ingress and ignore other sources of permeability.

Adaptability is crucial for developers as they upscale the production of viral vectors. Explore the benefits of using suspension cell lines and why adherent cell culture shouldn’t be left behind.

Explore how to select the right partner in the medical device supply industry to avoid supply chain breakdowns in product quality, delivery, or availability that could endanger patient health.

When optimizing your organization's buffer use, learn about the steps of buffer development, choosing a supply approach and strategy, choosing between in-house and outsourcing buffer activities, and more.

Learn more about platform technologies that are being developed and implemented to support large-scale production of viral vectors.

This study provides preliminary evidence for impact on overall yield and quality of the AAV due to a timed osmolality shift with and without a feeding step.

An optimized upstream manufacturing process is crucial for producing the necessary amount of plasmid DNA required for the growing number of therapeutic and vaccine applications available.

Implementing integrated solutions can provide cell and gene therapy manufacturing systems that work in concert to create a closed, automated, scalable, and performance-qualified network of unit operations.

Explore challenges found in various analytical techniques during the purification process of viral vectors, particularly with regard to downstream purification of adeno-associated viruses (AAVs).

There are certain roles that must be filled before you move into manufacturing to avoid costly delays and incur non-value-added expenses. Discover what those roles are and get ideas on how to fill them.

China is leading the world in oncology and CAR-T research. And with over a billion people and a government friendly to biotech, it’s an ideal location for international clinical trials.

Learn how embracing digital transformation through the use of distributed automation and digital plant maturity can support productivity, efficiency, and resilience in biomanufacturing.

Learn about a family of centrifuges and review of data collected on the centrifuges' performance for the harvest of cells in cell therapy production.

Explore the impact of the 4G/5G transition on the life sciences supply chain, how this change can resolve current supply chain issues, and precautions to take when adopting 5G-enabled technologies.

Learn more about the platform-based scalable suspension process for LVV production and how it is impacting CGTs advancing toward commercialization.

Speakers from leading institutions and organizations discuss the current state of precision medicine, the effective models they use in their research, and the future applications.